Novolog Pharm-Up 1966 Ltd (TA:NVLG) — Stock Price
Novolog Pharm-Up 1966 Ltd (TA:NVLG) is currently trading at ILA78.40 ILA, down 4.62% today. Over the past 52 weeks, shares have ranged between ILA66.80 and ILA153.00. This page tracks Novolog Pharm-Up 1966 Ltd's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Novolog Pharm-Up 1966 Ltd (NVLG) total market value.
Novolog Pharm-Up 1966 Ltd (NVLG) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Novolog Pharm-Up 1966 Ltd's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Novolog Pharm-Up 1966 Ltd Income Statement — Revenue, Profit & Earnings by Year
Novolog Pharm-Up 1966 Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ILA1.81 Billion | ILA2.02 Billion | ILA1.64 Billion | ILA1.51 Billion | ILA1.26 Billion |
| Cost of Revenue | ILA1.68 Billion | ILA1.84 Billion | ILA1.47 Billion | ILA1.33 Billion | ILA1.11 Billion |
| Gross Profit | ILA124.09 Million | ILA180.78 Million | ILA173.76 Million | ILA176.15 Million | ILA148.96 Million |
| Research & Development | — | — | — | ILA536.00K | — |
| SG&A | ILA24.46 Million | ILA10.11 Million | ILA118.69 Million | ILA9.04 Million | ILA7.81 Million |
| Total Operating Expenses | ILA97.69 Million | ILA118.43 Million | ILA171.11 Million | ILA97.64 Million | ILA81.10 Million |
| Operating Income | ILA26.40 Million | ILA62.35 Million | ILA2.65 Million | ILA78.78 Million | ILA69.94 Million |
| EBITDA | ILA100.75 Million | ILA149.39 Million | ILA130.14 Million | ILA138.53 Million | ILA115.92 Million |
| EBIT | ILA26.40 Million | ILA70.73 Million | ILA14.60 Million | ILA85.04 Million | ILA70.24 Million |
| Interest Expense | ILA19.27 Million | ILA12.61 Million | ILA12.87 Million | ILA12.54 Million | ILA8.47 Million |
| Income Before Tax | ILA6.83 Million | ILA57.68 Million | ILA1.73 Million | ILA73.14 Million | ILA61.77 Million |
| Income Tax Expense | ILA2.33 Million | ILA16.69 Million | ILA10.47 Million | ILA17.13 Million | ILA15.30 Million |
| Net Income | ILA4.12 Million | ILA39.54 Million | ILA-42.00 Million | ILA47.51 Million | ILA42.32 Million |
Novolog Pharm-Up 1966 Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Novolog Pharm-Up 1966 Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ILA2.15 Billion | ILA3.04 Billion | ILA2.79 Billion | ILA2.43 Billion | ILA2.29 Billion |
| Total Current Assets | ILA1.46 Billion | ILA2.37 Billion | ILA2.11 Billion | ILA1.72 Billion | ILA1.74 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | ILA1.07 Billion | ILA1.76 Billion | ILA1.56 Billion | ILA1.31 Billion | ILA1.29 Billion |
| Inventory | ILA250.78 Million | ILA315.07 Million | ILA247.33 Million | ILA189.03 Million | ILA186.79 Million |
| Property, Plant & Equipment | — | — | — | ILA306.62 Million | ILA224.77 Million |
| Goodwill | ILA145.04 Million | ILA156.20 Million | ILA162.69 Million | ILA214.33 Million | ILA161.06 Million |
| Total Liabilities | ILA1.78 Billion | ILA2.65 Billion | ILA2.39 Billion | ILA1.97 Billion | ILA1.86 Billion |
| Total Current Liabilities | ILA1.60 Billion | ILA2.46 Billion | ILA2.18 Billion | ILA1.76 Billion | ILA1.69 Billion |
| Long-term Debt | — | ILA0.00 | ILA73.00K | ILA967.00K | ILA916.00K |
| Net Debt | ILA61.44 Million | ILA-49.12 Million | ILA-17.76 Million | ILA39.97 Million | ILA-71.90 Million |
| Total Stockholder Equity | ILA356.85 Million | ILA368.38 Million | ILA371.08 Million | ILA436.00 Million | ILA424.37 Million |
| Retained Earnings | ILA16.32 Million | ILA32.21 Million | ILA32.67 Million | ILA91.58 Million | ILA75.97 Million |
Novolog Pharm-Up 1966 Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Novolog Pharm-Up 1966 Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ILA-16.50 Million | ILA158.52 Million | ILA200.01 Million | ILA132.65 Million | ILA83.39 Million |
| Capital Expenditures | ILA17.72 Million | ILA58.74 Million | ILA70.95 Million | ILA69.49 Million | ILA30.64 Million |
| Free Cash Flow | ILA-34.22 Million | ILA99.78 Million | ILA129.06 Million | ILA63.16 Million | ILA52.75 Million |
| Investing Cash Flow | ILA-61.92 Million | ILA-50.55 Million | ILA-72.60 Million | ILA-124.95 Million | ILA-69.07 Million |
| Financing Cash Flow | ILA-46.02 Million | ILA-94.59 Million | ILA-67.71 Million | ILA-72.96 Million | ILA47.49 Million |
| Dividends Paid | ILA20.00 Million | ILA40.00 Million | ILA16.90 Million | ILA31.90 Million | ILA32.00 Million |
| Stock-Based Compensation | ILA3.70 Million | ILA3.20 Million | ILA-155.00K | ILA2.35 Million | ILA2.58 Million |
| Depreciation | ILA74.36 Million | ILA78.66 Million | ILA115.54 Million | ILA52.85 Million | ILA45.69 Million |
| Change in Cash | ILA-125.83 Million | ILA14.66 Million | ILA60.13 Million | ILA-65.90 Million | ILA62.27 Million |
Novolog Pharm-Up 1966 Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Novolog Pharm-Up 1966 Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Novolog Pharm-Up 1966 Ltd.